Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 1
2006 1
2008 1
2012 1
2014 1
2017 2
2018 2
2020 2
2021 2
2022 8
2023 25
2024 358
2025 3482
2026 279

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,019 results

Results by year

Filters applied: in the last 1 year. Clear all
Page 1
Atopic dermatitis.
Guttman-Yassky E, Renert-Yuval Y, Brunner PM. Guttman-Yassky E, et al. Lancet. 2025 Feb 15;405(10478):583-596. doi: 10.1016/S0140-6736(24)02519-4. Lancet. 2025. PMID: 39955121 Review.
Atopic dermatitis is part of a spectrum of atopic conditions that can also include several non-cutaneous organs such as respiratory (eg, allergic rhinitis and asthma) and gastrointestinal (eg, food allergy) systems. ...The updated pathophysiological understan …
Atopic dermatitis is part of a spectrum of atopic conditions that can also include several non-cutaneous organs such as …
Update on atopic dermatitis.
Meledathu S, Naidu MP, Brunner PM. Meledathu S, et al. J Allergy Clin Immunol. 2025 Apr;155(4):1124-1132. doi: 10.1016/j.jaci.2025.01.013. Epub 2025 Jan 22. J Allergy Clin Immunol. 2025. PMID: 39855361 Free article. Review.
Atopic dermatitis is the most common chronic inflammatory skin condition. This review highlights most recent advances in understanding and treating this debilitating disease. We summarize new insights regarding molecular endotypes and clinical phenotypes that charac …
Atopic dermatitis is the most common chronic inflammatory skin condition. This review highlights most recent advances in under …
Endotypes of atopic dermatitis.
Fyhrquist N, Yang Y, Karisola P, Alenius H. Fyhrquist N, et al. J Allergy Clin Immunol. 2025 Jul;156(1):24-40.e4. doi: 10.1016/j.jaci.2025.02.029. Epub 2025 Mar 5. J Allergy Clin Immunol. 2025. PMID: 40054744 Free article. Review.
Atopic dermatitis (AD) is a chronic, heterogeneous skin condition driven by a combination of genetic, immune, and environmental factors. ...
Atopic dermatitis (AD) is a chronic, heterogeneous skin condition driven by a combination of genetic, immune, and environmenta …
Executive summary: Japanese guidelines for atopic dermatitis (ADGL) 2024.
Saeki H, Ohya Y, Arakawa H, Ichiyama S, Katsunuma T, Katoh N, Tanaka A, Tanizaki H, Tsunemi Y, Nakahara T, Nagao M, Narita M, Hide M, Fujisawa T, Futamura M, Masuda K, Matsubara T, Murota H, Yamamoto-Hanada K, Furuta J; Committee for Clinical Practice Guidelines for the Management of Atopic Dermatitis 2024; Japanese Society of Allergology; Japanese Dermatology Association. Saeki H, et al. Allergol Int. 2025 Apr;74(2):210-221. doi: 10.1016/j.alit.2025.01.003. Epub 2025 Feb 21. Allergol Int. 2025. PMID: 39986987 Free article.
This is an abridged edition of English version of the Clinical Practice Guidelines for the Management of Atopic Dermatitis 2024. Atopic dermatitis (AD) is a disease characterized by relapsing eczema with pruritus as a primary lesion. ...
This is an abridged edition of English version of the Clinical Practice Guidelines for the Management of Atopic Dermatitis 202 …
Comparative efficacy and safety of ilunocitinib and oclacitinib for the control of pruritus and associated skin lesions in dogs with atopic dermatitis.
Forster S, Boegel A, Despa S, Trout C, King S. Forster S, et al. Vet Dermatol. 2025 Apr;36(2):165-176. doi: 10.1111/vde.13319. Epub 2025 Jan 6. Vet Dermatol. 2025. PMID: 39757965 Free PMC article.
BACKGROUND: Janus kinase inhibitors (JAKi) have been shown to reduce pruritus and improve associated inflammatory skin lesions in canine atopic dermatitis (cAD). OBJECTIVE: To evaluate the efficacy and safety of ilunocitinib, in comparison to oclacitinib, for the co …
BACKGROUND: Janus kinase inhibitors (JAKi) have been shown to reduce pruritus and improve associated inflammatory skin lesions in canine …
Atopic Dermatitis: Update on Skin-Directed Management: Clinical Report.
Schoch JJ, Anderson KR, Jones AE, Tollefson MM; Section on Dermatology. Schoch JJ, et al. Pediatrics. 2025 Jun 1;155(6):e2025071812. doi: 10.1542/peds.2025-071812. Pediatrics. 2025. PMID: 40383540 Review.
Atopic dermatitis affects 20% to 25% of children and has significant impact on quality of life of patients and families. ...
Atopic dermatitis affects 20% to 25% of children and has significant impact on quality of life of patients and families. ...
Atopic Dermatitis: The Relationship Between Immune Mediators and Skin Lipid Barrier.
You H, Liang Y. You H, et al. Clin Rev Allergy Immunol. 2025 May 14;68(1):49. doi: 10.1007/s12016-025-09057-y. Clin Rev Allergy Immunol. 2025. PMID: 40366491 Review.
Atopic dermatitis (AD) is a chronic inflammatory skin disease that is prevalent worldwide with complex etiology. ...
Atopic dermatitis (AD) is a chronic inflammatory skin disease that is prevalent worldwide with complex etiology. ...
AP2M1 as the potential biomarker for prediction of the response of atopic dermatitis to Dupilumab therapy: Multi-omics analysis and evidence.
Peng S, Yan W, Yan Y, Tang Q, Feng H, Huang X. Peng S, et al. Int J Biol Macromol. 2025 Mar;297:139757. doi: 10.1016/j.ijbiomac.2025.139757. Epub 2025 Jan 14. Int J Biol Macromol. 2025. PMID: 39818381
Many atopic dermatitis (AD) patients have suboptimal responses to Dupilumab therapy. This study identified key genes linked to this resistance using multi-omics approaches to benefit more patients. ...
Many atopic dermatitis (AD) patients have suboptimal responses to Dupilumab therapy. This study identified key genes linked to …
[Atopic dermatitis].
Wienholtz NK, Vestergaard C, Deleuran M, Drljevic-Nielsen A, Andersson AM. Wienholtz NK, et al. Ugeskr Laeger. 2025 Mar 31;187(14):V10240722. doi: 10.61409/V10240722. Ugeskr Laeger. 2025. PMID: 40171906 Free article. Review. Danish.
Atopic dermatitis is a common, chronic, inflammatory skin disorder that primarily affects children but can continue into adulthood. In this review we describe that the cause of atopic dermatitis is a combination of genetic, immunological, and environme …
Atopic dermatitis is a common, chronic, inflammatory skin disorder that primarily affects children but can continue into adult …
Deciding Which Patients With Atopic Dermatitis to Prioritize for Biologics and Janus Kinase Inhibitors.
Kamata M, Sun DI, Paller AS. Kamata M, et al. J Allergy Clin Immunol Pract. 2025 Aug;13(8):1901-1910.e1. doi: 10.1016/j.jaip.2025.04.042. Epub 2025 May 12. J Allergy Clin Immunol Pract. 2025. PMID: 40368249 Review.
Atopic dermatitis (AD) is a common, chronic inflammatory skin disorder associated with reduced quality of life related to itch, sleep disturbance, risk of cutaneous infections, mental health issues, and high caregiver stress. ...Dupilumab, the first available biolog …
Atopic dermatitis (AD) is a common, chronic inflammatory skin disorder associated with reduced quality of life related to itch …
3,019 results